GDF2 and pulmonary arterial hypertension: Daily injections of BMP9 into a hereditary pulmonary arterial hypertension model mouse harboring a heterozygous R899X mutation in BMPR2 ameliorates the established pulmonary arterial hypertension phenotype, supporting a therapeutic potential of BMP9 for pulmonary arterial hypertension30.